381 related articles for article (PubMed ID: 30526440)
1. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.
Keeratichananont W; Kaewdech A; Keeratichananont S
Ther Adv Respir Dis; 2018; 12():1753466618816625. PubMed ID: 30526440
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion.
Keeratichananont W; Limthon T; Keeratichananont S
Ther Adv Respir Dis; 2015 Apr; 9(2):42-8. PubMed ID: 25663279
[TBL] [Abstract][Full Text] [Related]
3. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
4. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
5. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
7. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma.
Nohara K; Takada K; Kojima E; Ninomiya K; Miyamatsu S; Shimizu T; Sakurai T; Mizuno T; Yamashita Y
Respir Investig; 2016 Sep; 54(5):341-6. PubMed ID: 27566382
[TBL] [Abstract][Full Text] [Related]
8. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
Bhatnagar R; Piotrowska HEG; Laskawiec-Szkonter M; Kahan BC; Luengo-Fernandez R; Pepperell JCT; Evison MD; Holme J; Al-Aloul M; Psallidas I; Lim WS; Blyth KG; Roberts ME; Cox G; Downer NJ; Herre J; Sivasothy P; Menzies D; Munavvar M; Kyi MM; Ahmed L; West AG; Harrison RN; Prudon B; Hettiarachchi G; Chakrabarti B; Kavidasan A; Sutton BP; Zahan-Evans NJ; Quaddy JL; Edey AJ; Clive AO; Walker SP; Little MHR; Mei XW; Harvey JE; Hooper CE; Davies HE; Slade M; Sivier M; Miller RF; Rahman NM; Maskell NA
JAMA; 2020 Jan; 323(1):60-69. PubMed ID: 31804680
[TBL] [Abstract][Full Text] [Related]
9. Is silver nitrate an effective means of pleurodesis?
Bucknor A; Harrison-Phipps K; Davies T; Toufektzian L
Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):521-5. PubMed ID: 26188199
[TBL] [Abstract][Full Text] [Related]
10. Talc pleurodesis in pleuropulmonary diseases treatment.
Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
[TBL] [Abstract][Full Text] [Related]
11. Management of recurrent malignant pleural effusion with chemical pleurodesis.
Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
14. Talc pleurodesis for the management of malignant pleural effusions in Japan.
Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect and tolerance of talc slurry for control of malignant pleural effusions.
Prevost A; Costa B; Elamarti R; Nazeyrollas P; Mallet F; Yazbek G; Cauchois A
Oncol Rep; 2001; 8(6):1327-31. PubMed ID: 11605059
[TBL] [Abstract][Full Text] [Related]
16. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion.
Beck TN; Deneka AY; Chai L; Kanach C; Johal P; Alvarez NJ; Boumber Y; Golemis EA; Laub GW
BMC Cancer; 2019 Jun; 19(1):614. PubMed ID: 31234819
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.
Ong KC; Indumathi V; Raghuram J; Ong YY
Respirology; 2000 Jun; 5(2):99-103. PubMed ID: 10894097
[TBL] [Abstract][Full Text] [Related]
18. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
Goodman A; Davies CW
Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
[TBL] [Abstract][Full Text] [Related]
20. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
